# Pediatrix Medical Group Announces Publication of New Research Addressing Urgent Questions in Neonatology
Canonical URL: https://biopharmsignal.com/news/MD/pediatrix-medical-group-announces-publication-of-new-research-addressing-urgent-questions-in-neonatology
Ticker: MD
Company: Pediatrix Medical Group, Inc.
Source: Pediatrix Medical Group, Inc.
Published: 2026-06-25 13:46 EST
Original Source URL: https://mednax.gcs-web.com
## Summary

Research Was Conducted Utilizing the Proprietary Pediatrix Clinical Data Warehouse FORT LAUDERDALE, Fla. --(BUSINESS WIRE)--Jun. 3, 2026-- Pediatrix® Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today announced the publication of new research on probiotic use and

## Article Body
Research Was Conducted Utilizing the Proprietary Pediatrix Clinical Data Warehouse FORT LAUDERDALE, Fla. --(BUSINESS WIRE)--Jun. 3, 2026-- Pediatrix® Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today announced the publication of new research on probiotic use and
## Recent Company News
- 2026-06-25 13:46 EST — [Pediatrix Medical Group Announces Publication of New Research Addressing Urgent Questions in Neonatology](https://biopharmsignal.com/news/MD/pediatrix-medical-group-announces-publication-of-new-research-addressing-urgent-questions-in-neonatology) — Source: Pediatrix Medical Group, Inc.
- 2026-06-25 13:46 EST — [Pediatrix Medical Group Announces $250 Million Share Repurchase Program](https://biopharmsignal.com/news/MD/pediatrix-medical-group-announces-250-million-share-repurchase-program) — Source: Pediatrix Medical Group, Inc.
- 2026-06-25 13:46 EST — [Pediatrix Medical Group 2025 Third Quarter Conference Call/Webcast Scheduled for Monday, November 3, 2025](https://biopharmsignal.com/news/MD/pediatrix-medical-group-2025-third-quarter-conference-call-webcast-scheduled-for-monday-november-3-2025) — Source: Pediatrix Medical Group, Inc.
- 2026-06-25 13:46 EST — [Pediatrix Medical Group Reports Third Quarter Results](https://biopharmsignal.com/news/MD/pediatrix-medical-group-reports-third-quarter-results) — Source: Pediatrix Medical Group, Inc.
- 2026-06-25 13:46 EST — [Pediatrix Medical Group 2025 Fourth Quarter Conference Call/Webcast Scheduled for Thursday, February 19, 2026](https://biopharmsignal.com/news/MD/pediatrix-medical-group-2025-fourth-quarter-conference-call-webcast-scheduled-for-thursday-february-19-2026) — Source: Pediatrix Medical Group, Inc.
## Related News
- 2026-07-21 12:00 EST — MOR — [Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed](https://biopharmsignal.com/news/MOR/novartis-delivered-sales-growth-in-q2-and-further-advanced-the-pipeline-full-yea-63a32b47)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)
- 2026-07-20 13:05 EST — ACAD — [Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis](https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c)
- 2026-07-20 13:00 EST — ENLV — [Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion](https://biopharmsignal.com/news/ENLV/enlivex-treasury-portfolio-update-nav-per-ordinary-share-66-16-total-treasury-ho-9d036ef9)